6533b82ffe1ef96bd1295245

RESEARCH PRODUCT

The diagnosis and management of gastric cancer: Expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010

E. Van CutsemM. DicatoR. GevaN. ArberY. BangA. BensonA. CervantesE. Diaz-rubioM. DucreuxR. Glynne-jonesAxel GrotheyD. HallerK. HaustermansD. KerrB. NordlingerJ. MarshallB. D. MinskyY. K. KangR. LabiancaF. LordickA. OhtsuNicholas PavlidisA. RothP. RougierH. J. SchmollA. SobreroJosep TaberneroC. Van De VeldeJ. ZalcbergE. Van CutsemM. DicatoR. GevaN. ArberY. BangA. BensonA. CervantesE. Diaz-rubioM. DucreuxR. Glynne-jonesAxel GrotheyD. HallerK. HaustermansD. KerrB. NordlingerJ. MarshallB. D. MinskyY. K. KangR. LabiancaF. LordickA. OhtsuNicholas PavlidisA. RothP. RougierH. J. SchmollA. SobreroJosep TaberneroC. Van De VeldeJ. Zalcberg

subject

Continuous infusionComputer assisted radiotherapyFolic acidFluorodeoxyglucose f 18Gimeracil plus oteracil potassium plus tegafurInfection controlIntensity modulated radiation therapyDocetaxelCancer stagingMetastatic gastric cancerRisk FactorsPrevalenceDrug fatalityOverall survivalNeoplasm MetastasisPriority journalddc:616Conference paperdigestive oral and skin physiologyFolinic acidHematologyPrognosisOxaliplatinNuclear magnetic resonance imagingBevacizumabSurvival RateOncologyCyanocobalaminPractice Guidelines as TopicDrug dose reductionFluorouracilEsophageal adenocarcinomaHumanPositron emission tomographymedicine.medical_specialtyNeutropeniaStomach cancerStomach neoplasmsMEDLINESide effectStomach adenocarcinomaPatient careIrinotecanHelicobacter infectionPrimary tumorEndoscopic echographyAdvanced cancerEndoscopic mucosal resectionComputer assisted tomographyStomach Neoplasms/*diagnosis/pathology/*therapymedicineHumansGenetic Predisposition to DiseaseGastrointestinal cancerPhase 3 clinical trial (topic)Intensive care medicineSurvival ratePlaceboCapecitabineEpirubicinCa 19-9 antigenStomach Neoplasms/diagnosis/pathology/therapyHelicobacter pyloribusiness.industryCancerTrastuzumabCardiovascular riskmedicine.diseaseCancer susceptibilitydigestive system diseasesSurgeryClinical trialMetastasis potentialExpert opinionMeta analysis (topic)Cancer adjuvant therapyCarcinoembryonic antigenLower esophagus sphincterCisplatinCaloric intakebusinessCancer incidenceRegional differences

description

Well-recognized experts in the field of gastric cancer discussed during the 12th European Society Medical Oncology (ESMO)/World Congress Gastrointestinal Cancer (WCGIC) in Barcelona many important and controversial topics on the diagnosis and management of patients with gastric cancer. This article summarizes the recommendations and expert opinion on gastric cancer. It discusses and reflects on the regional differences in the incidence and care of gastric cancer, the definition of gastro-esophageal junction and its implication for treatment strategies and presents the latest recommendations in the staging and treatment of primary and metastatic gastric cancer. Recognition is given to the need for larger and well-designed clinical trials to answer many open questions. © The Author 2011. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. 22 SUPPL. 5 v1 v9

yearjournalcountryeditionlanguage
2011-06-30Annals of Oncology
10.1093/annonc/mdr284http://ora.ox.ac.uk/objects/uuid:b15cad0c-adcc-4980-9ee0-6f33b0ed79a8